Inactive

This Sources Sought Notice (SSN) is posted to conduct market research for capabilities from potential sources for a supply of TPOXX (tecovirimat) treatment courses. This is a SSN for planning purposes... This Sources Sought Notice (SSN) is posted to conduct market research for capabilities from potential sources for a supply of TPOXX (tecovirimat) treatment courses. This is a SSN for planning purposes only, as defined in FAR 15.201(e). This is not a solicitation for proposals. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited. No solicitation document exists or is guaranteed to be issued as a result of this SSN. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback. This information will support Joint Project Manager Medical (JPM Medical), a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). As such, JPM Medical is seeking the following information on current industry capabilities to supply TPOXX treatment courses. SUBMISSION INSTRUCTIONS: All written responses must be received within fifteen (10) days of issuance of this SSN. Submissions should: (1) Use Microsoft Word or Adobe Portable Document Format (PDF); (2) Be sent to the POC identified below by email only; (3) Be complete, sufficiently detailed, and organized in a manner that tracks to the information requested in this SSN; (4) Include a single company point of contact with name, title, address, telephone and fax numbers, and e-mail address(s); and (5) Not exceed 10 single sided pages in total (not including cover page and cover letter). Material that is advertisement only in nature is not desired. Please address responses to this notice to the Government Contract Specialist, Kenneth Janosko: kenneth.v.janosko.civ@army.mil. Please title the response with the announcement number, company name, and date. All questions must be submitted in writing via email. No telephone inquiries will be accepted.